Karyopharm Therapeutics Inc. (KPTI) stock
KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.04−0.01 (-20.00%)
Close on Nov 9, 2026Market cap $1.16KP/E –Yield –
Karyopharm Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Karyopharm Therapeutics's total assets was $111.32M at Jun 30, 2026. For fiscal 2025 it was $108.42M, down 34.1% from the year before. Over ten years it grew -6.6% a year on average. The highest annual figure on record is $358.17M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $108.42M | -34.1% |
| FY2024 | Dec 31, 2024 | $164.42M | -31.6% |
| FY2023 | Dec 31, 2023 | $240.44M | -32.9% |
| FY2022 | Dec 31, 2022 | $358.17M | +17.3% |
| FY2021 | Dec 31, 2021 | $305.31M | -2.5% |
| FY2020 | Dec 31, 2020 | $313.05M | +6.1% |
| FY2019 | Dec 31, 2019 | $294.96M | -13.5% |
| FY2018 | Dec 31, 2018 | $341.19M | +89.2% |
| FY2017 | Dec 31, 2017 | $180.29M | -0.1% |
| FY2016 | Dec 31, 2016 | $180.39M | -16.3% |
| FY2015 | Dec 31, 2015 | $215.44M | -2.2% |
| FY2014 | Dec 31, 2014 | $220.34M | +39.3% |
| FY2013 | Dec 31, 2013 | $158.23M | +11969.1% |
| FY2012 | Dec 31, 2012 | $1.31M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $111.32M | +6.1% |
| Q1 FY2026 | Mar 31, 2026 | $131.42M | +2.9% |
| Q4 FY2025 | Dec 31, 2025 | $108.42M | -34.1% |
| Q3 FY2025 | Sep 30, 2025 | $96.23M | -49.2% |
| Q2 FY2025 | Jun 30, 2025 | $104.88M | -51.0% |
| Q1 FY2025 | Mar 31, 2025 | $127.71M | -37.5% |
| Q4 FY2024 | Dec 31, 2024 | $164.42M | -31.6% |
| Q3 FY2024 | Sep 30, 2024 | $189.48M | -29.8% |
| Q2 FY2024 | Jun 30, 2024 | $213.98M | -28.2% |
| Q1 FY2024 | Mar 31, 2024 | $204.46M | -37.2% |
| Q4 FY2023 | Dec 31, 2023 | $240.44M | -32.9% |
| Q3 FY2023 | Sep 30, 2023 | $269.96M | +16.7% |
| Q2 FY2023 | Jun 30, 2023 | $297.83M | +16.1% |
| Q1 FY2023 | Mar 31, 2023 | $325.80M | +10.8% |
| Q4 FY2022 | Dec 31, 2022 | $358.17M | +17.3% |
| Q3 FY2022 | Sep 30, 2022 | $231.24M | -9.0% |
| Q2 FY2022 | Jun 30, 2022 | $256.48M | -10.5% |
| Q1 FY2022 | Mar 31, 2022 | $294.03M | +7.0% |
| Q4 FY2021 | Dec 31, 2021 | $305.31M | -2.5% |
| Q3 FY2021 | Sep 30, 2021 | $254.09M | -24.7% |
| Q2 FY2021 | Jun 30, 2021 | $286.57M | -24.6% |
| Q1 FY2021 | Mar 31, 2021 | $274.91M | -33.9% |
| Q4 FY2020 | Dec 31, 2020 | $313.05M | +6.1% |
| Q3 FY2020 | Sep 30, 2020 | $337.59M | +13.4% |
| Q2 FY2020 | Jun 30, 2020 | $380.01M | +59.6% |
| Q1 FY2020 | Mar 31, 2020 | $416.14M | +44.9% |
| Q4 FY2019 | Dec 31, 2019 | $294.96M | -13.5% |
| Q3 FY2019 | Sep 30, 2019 | $297.75M | +35.3% |
| Q2 FY2019 | Jun 30, 2019 | $238.10M | -7.2% |
| Q1 FY2019 | Mar 31, 2019 | $287.21M | +96.2% |
| Q4 FY2018 | Dec 31, 2018 | $341.19M | +89.2% |
| Q3 FY2018 | Sep 30, 2018 | $219.99M | +34.3% |
| Q2 FY2018 | Jun 30, 2018 | $256.59M | +38.1% |
| Q1 FY2018 | Mar 31, 2018 | $146.37M | -5.8% |
| Q4 FY2017 | Dec 31, 2017 | $180.29M | -0.1% |
| Q3 FY2017 | Sep 30, 2017 | $163.77M | -10.8% |
| Q2 FY2017 | Jun 30, 2017 | $185.75M | – |
| Q1 FY2017 | Mar 31, 2017 | $155.44M | – |
| Q4 FY2016 | Dec 31, 2016 | $180.39M | – |
| Q3 FY2016 | Sep 30, 2016 | $183.62M | – |
See a number that looks wrong?